BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 29471287)

  • 1. Preoperative Grading of Glioma Using Dynamic Susceptibility Contrast MRI: Relative Cerebral Blood Volume Analysis of Intra-tumoural and Peri-tumoural Tissue.
    Soliman RK; Gamal SA; Essa AA; Othman MH
    Clin Neurol Neurosurg; 2018 Apr; 167():86-92. PubMed ID: 29471287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Texture analysis of apparent diffusion coefficient (ADC) map for glioma grading: Analysis of whole tumoral and peri-tumoral tissue.
    Soliman RK; Essa AA; Elhakeem AAS; Gamal SA; Zaitoun MMA
    Diagn Interv Imaging; 2021 May; 102(5):287-295. PubMed ID: 33419692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relative cerebral blood volume values to differentiate high-grade glioma recurrence from posttreatment radiation effect: direct correlation between image-guided tissue histopathology and localized dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging measurements.
    Hu LS; Baxter LC; Smith KA; Feuerstein BG; Karis JP; Eschbacher JM; Coons SW; Nakaji P; Yeh RF; Debbins J; Heiserman JE
    AJNR Am J Neuroradiol; 2009 Mar; 30(3):552-8. PubMed ID: 19056837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assesment of perfusion in glial tumors with arterial spin labeling; comparison with dynamic susceptibility contrast method.
    Cebeci H; Aydin O; Ozturk-Isik E; Gumus C; Inecikli F; Bekar A; Kocaeli H; Hakyemez B
    Eur J Radiol; 2014 Oct; 83(10):1914-9. PubMed ID: 25087109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic resonance perfusion for differentiating low-grade from high-grade gliomas at first presentation.
    Abrigo JM; Fountain DM; Provenzale JM; Law EK; Kwong JS; Hart MG; Tam WWS
    Cochrane Database Syst Rev; 2018 Jan; 1(1):CD011551. PubMed ID: 29357120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percentage signal intensity recovery: A step ahead of rCBV in DSC MR perfusion imaging for the differentiation of common neoplasms of brain.
    Surendra KL; Patwari S; Agrawal S; Chadaga H; Nagadi A
    Indian J Cancer; 2020; 57(1):36-43. PubMed ID: 31898591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamic contrast-enhanced and dynamic susceptibility contrast perfusion MR imaging for glioma grading: Preliminary comparison of vessel compartment and permeability parameters using hotspot and histogram analysis.
    Santarosa C; Castellano A; Conte GM; Cadioli M; Iadanza A; Terreni MR; Franzin A; Bello L; Caulo M; Falini A; Anzalone N
    Eur J Radiol; 2016 Jun; 85(6):1147-56. PubMed ID: 27161065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic accuracy of automatic normalization of CBV in glioma grading using T1- weighted DCE-MRI.
    Sahoo P; Gupta RK; Gupta PK; Awasthi A; Pandey CM; Gupta M; Patir R; Vaishya S; Ahlawat S; Saha I
    Magn Reson Imaging; 2017 Dec; 44():32-37. PubMed ID: 28827098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiation of primary central nervous system lymphomas from high-grade gliomas by rCBV and percentage of signal intensity recovery derived from dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging.
    Xing Z; You RX; Li J; Liu Y; Cao DR
    Clin Neuroradiol; 2014 Dec; 24(4):329-36. PubMed ID: 23994941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic Values of DCE-MRI and DSC-MRI for Differentiation Between High-grade and Low-grade Gliomas: A Comprehensive Meta-analysis.
    Liang J; Liu D; Gao P; Zhang D; Chen H; Shi C; Luo L
    Acad Radiol; 2018 Mar; 25(3):338-348. PubMed ID: 29223713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of diffusion tensor imaging in differentiating high-grade from low-grade gliomas.
    Piyapittayanan S; Chawalparit O; Tritakarn SO; Witthiwej T; Sangruchi T; Nunta-Aree S; Sathornsumetee S; Itthimethin P; Komoltri C
    J Med Assoc Thai; 2013 Jun; 96(6):716-21. PubMed ID: 23951830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigating dynamic susceptibility contrast-enhanced perfusion-weighted magnetic resonance imaging in posterior fossa tumors: differences and similarities with supratentorial tumors.
    Gaudino S; Benenati M; Martucci M; Botto A; Infante A; Marrazzo A; Ramaglia A; Marziali G; Guadalupi P; Colosimo C
    Radiol Med; 2020 Apr; 125(4):416-422. PubMed ID: 31916104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-grade and low-grade gliomas: differentiation by using perfusion MR imaging.
    Hakyemez B; Erdogan C; Ercan I; Ergin N; Uysal S; Atahan S
    Clin Radiol; 2005 Apr; 60(4):493-502. PubMed ID: 15767107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of diagnostic accuracy of perfusion MR imaging in primary and metastatic solitary malignant brain tumors.
    Bulakbasi N; Kocaoglu M; Farzaliyev A; Tayfun C; Ucoz T; Somuncu I
    AJNR Am J Neuroradiol; 2005 Oct; 26(9):2187-99. PubMed ID: 16219821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glioma grading: sensitivity, specificity, positive and negative predictive values of diffusion and perfusion imaging.
    Arvinda HR; Kesavadas C; Sarma PS; Thomas B; Radhakrishnan VV; Gupta AK; Kapilamoorthy TR; Nair S
    J Neurooncol; 2009 Aug; 94(1):87-96. PubMed ID: 19229590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amide proton transfer imaging to discriminate between low- and high-grade gliomas: added value to apparent diffusion coefficient and relative cerebral blood volume.
    Choi YS; Ahn SS; Lee SK; Chang JH; Kang SG; Kim SH; Zhou J
    Eur Radiol; 2017 Aug; 27(8):3181-3189. PubMed ID: 28116517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Value of relative cerebral blood volume measurement using perfusion MRI in glioma management].
    Metellus P; Dutertre G; Mekkaoui C; Nanni I; Fuentes S; Ait-Ameur A; Chinot O; Dufour H; Figarella-Branger D; Cordoliani YS; Grisoli F
    Neurochirurgie; 2008 Aug; 54(4):503-11. PubMed ID: 18573509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relative percentage signal intensity recovery of perfusion metrics—an efficient tool for differentiating grades of glioma.
    Smitha KA; Gupta AK; Jayasree RS
    Br J Radiol; 2015 Aug; 88(1052):20140784. PubMed ID: 26110202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective glioma grading using single-dose dynamic contrast-enhanced perfusion MRI.
    Jain KK; Sahoo P; Tyagi R; Mehta A; Patir R; Vaishya S; Prakash N; Vasudev N; Gupta RK
    Clin Radiol; 2015 Oct; 70(10):1128-35. PubMed ID: 26152879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perfusion MRI (dynamic susceptibility contrast imaging) with different measurement approaches for the evaluation of blood flow and blood volume in human gliomas.
    Thomsen H; Steffensen E; Larsson EM
    Acta Radiol; 2012 Feb; 53(1):95-101. PubMed ID: 22114021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.